Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind Controlled Phase 4 Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency

NCT01453608 is registered in ClinicalTrials.gov with Vifor Pharma as lead sponsor.

NCT NCT01453608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01453608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind Controlled Phase 4 Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
Lead sponsor
Vifor Pharma
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
January 31, 2015
Enrollment
304 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, iron deficiency